Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Diabetes research in primary care: fiction, reality or essential?.

Diabetic medicine : a journal of the British Diabetic Association

Khunti K, Seidu S.
PMID: 29653466
Diabet Med. 2018 Jul;35(7):832-834. doi: 10.1111/dme.13638.

No abstract available.

Cite
Khunti K, Seidu S. Diabetes research in primary care: fiction, reality or essential?. Diabet Med. 2018;35(7):832-834doi: 10.1111/dme.13638.
Khunti, K., & Seidu, S. (2018). Diabetes research in primary care: fiction, reality or essential?. Diabetic medicine : a journal of the British Diabetic Association, 35(7), 832-834. https://doi.org/10.1111/dme.13638
Khunti, K, and Seidu, S. "Diabetes research in primary care: fiction, reality or essential?." Diabetic medicine : a journal of the British Diabetic Association vol. 35,7 (2018): 832-834. doi: https://doi.org/10.1111/dme.13638
Khunti K, Seidu S. Diabetes research in primary care: fiction, reality or essential?. Diabet Med. 2018 Jul;35(7):832-834. doi: 10.1111/dme.13638. PMID: 29653466.
Copy Download .nbib Format: NLM
Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings.

Preventing chronic disease

Glasgow RE, Estabrooks PE.
PMID: 29300695
Prev Chronic Dis. 2018 Jan 04;15:E02. doi: 10.5888/pcd15.170271.

The RE-AIM (Reach Effectiveness Adoption Implementation Maintenance) planning and evaluation framework has been applied broadly, but users often have difficulty in applying the model because of data collection needs across multiple domains and sources. Questions in the more common...

Cite
Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings. Prev Chronic Dis. 2018;15:E02doi: 10.5888/pcd15.170271.
Glasgow, R. E., & Estabrooks, P. E. (2018). Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings. Preventing chronic disease, 15E02. https://doi.org/10.5888/pcd15.170271
Glasgow, Russell E, and Estabrooks, Paul E. "Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings." Preventing chronic disease vol. 15 (2018): E02. doi: https://doi.org/10.5888/pcd15.170271
Glasgow RE, Estabrooks PE. Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings. Prev Chronic Dis. 2018 Jan 04;15:E02. doi: 10.5888/pcd15.170271. PMID: 29300695; PMCID: PMC5757385.
Copy Download .nbib Format: NLM
TwiC or treat? Are trials within cohorts ethically defensible?.

Clinical trials (London, England)

Weijer C, Goldstein CE, Taljaard M.
PMID: 29250989
Clin Trials. 2018 Feb;15(1):21-24. doi: 10.1177/1740774517746622. Epub 2017 Dec 17.

No abstract available.

Cite
Weijer C, Goldstein CE, Taljaard M. TwiC or treat? Are trials within cohorts ethically defensible?. Clin Trials. 2017;15(1):21-24doi: 10.1177/1740774517746622.
Weijer, C., Goldstein, C. E., & Taljaard, M. (2018). TwiC or treat? Are trials within cohorts ethically defensible?. Clinical trials (London, England), 15(1), 21-24. https://doi.org/10.1177/1740774517746622
Weijer, Charles, et al. "TwiC or treat? Are trials within cohorts ethically defensible?." Clinical trials (London, England) vol. 15,1 (2018): 21-24. doi: https://doi.org/10.1177/1740774517746622
Weijer C, Goldstein CE, Taljaard M. TwiC or treat? Are trials within cohorts ethically defensible?. Clin Trials. 2018 Feb;15(1):21-24. doi: 10.1177/1740774517746622. Epub 2017 Dec 17. PMID: 29250989; PMCID: PMC5802521.
Copy Download .nbib Format: NLM
Let’s be pragmatic.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Stensrud MJ.
PMID: 31062548
Tidsskr Nor Laegeforen. 2019 May 06;139(8). doi: 10.4045/tidsskr.19.0059. Print 2019 May 07.

No abstract available.

Cite
Stensrud MJ. La oss være pragmatiske. Let’s be pragmatic. Tidsskr Nor Laegeforen. 2019;139(8)doi: 10.4045/tidsskr.19.0059.
Stensrud, M. J. (2019). La oss være pragmatiske. Let’s be pragmatic. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 139(8), . https://doi.org/10.4045/tidsskr.19.0059
Stensrud, Mats Julius. "La oss være pragmatiske." Let’s be pragmatic. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 139,8 (2019). doi: https://doi.org/10.4045/tidsskr.19.0059
Stensrud MJ. La oss være pragmatiske. Let’s be pragmatic. Tidsskr Nor Laegeforen. 2019 May 06;139(8). doi: 10.4045/tidsskr.19.0059. Print 2019 May 07. Norwegian. PMID: 31062548.
Copy Download .nbib Format: NLM
Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial.

BMC medical research methodology

Baier RR, Jutkowitz E, Mitchell SL, McCreedy E, Mor V.
PMID: 31319789
BMC Med Res Methodol. 2019 Jul 18;19(1):156. doi: 10.1186/s12874-019-0794-9.

BACKGROUND: Pragmatic randomized, controlled trials (PCTs) test the effectiveness of interventions implemented in routine clinical practice. Because PCT findings are generalizable, this approach is gaining momentum among interventionists and funding agencies seeking to accelerate the testing and adoption of...

Cite
Baier RR, Jutkowitz E, Mitchell SL, et al. Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial. BMC Med Res Methodol. 2019;19(1):156doi: 10.1186/s12874-019-0794-9.
Baier, R. R., Jutkowitz, E., Mitchell, S. L., McCreedy, E., & Mor, V. (2019). Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial. BMC medical research methodology, 19(1), 156. https://doi.org/10.1186/s12874-019-0794-9
Baier, Rosa R, et al. "Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial." BMC medical research methodology vol. 19,1 (2019): 156. doi: https://doi.org/10.1186/s12874-019-0794-9
Baier RR, Jutkowitz E, Mitchell SL, McCreedy E, Mor V. Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial. BMC Med Res Methodol. 2019 Jul 18;19(1):156. doi: 10.1186/s12874-019-0794-9. PMID: 31319789; PMCID: PMC6637482.
Copy Download .nbib Format: NLM
Building a National Program for Pilot Studies of Embedded Pragmatic Clinical Trials in Dementia Care.

Journal of the American Geriatrics Society

Brody AA, Barnes DE, Chodosh J, Galvin JE, Hepburn KW, Troxel AB, Hom K, McCarthy EP, Unroe KT.
PMID: 32589282
J Am Geriatr Soc. 2020 Jul;68:S14-S20. doi: 10.1111/jgs.16618.

Sixteen million caregivers currently provide care to more than 5 million persons living with dementia (PLWD) in the United States. Although this population is growing and highly complex, evidence-based management remains poorly integrated within healthcare systems. Therefore, the National...

Cite
Brody AA, Barnes DE, Chodosh J, et al. Building a National Program for Pilot Studies of Embedded Pragmatic Clinical Trials in Dementia Care. J Am Geriatr Soc. 2020;68:S14-S20doi: 10.1111/jgs.16618.
Brody, A. A., Barnes, D. E., Chodosh, J., Galvin, J. E., Hepburn, K. W., Troxel, A. B., Hom, K., McCarthy, E. P., & Unroe, K. T. (2020). Building a National Program for Pilot Studies of Embedded Pragmatic Clinical Trials in Dementia Care. Journal of the American Geriatrics Society, 68S14-S20. https://doi.org/10.1111/jgs.16618
Brody, Abraham A, et al. "Building a National Program for Pilot Studies of Embedded Pragmatic Clinical Trials in Dementia Care." Journal of the American Geriatrics Society vol. 68 (2020): S14-S20. doi: https://doi.org/10.1111/jgs.16618
Brody AA, Barnes DE, Chodosh J, Galvin JE, Hepburn KW, Troxel AB, Hom K, McCarthy EP, Unroe KT. Building a National Program for Pilot Studies of Embedded Pragmatic Clinical Trials in Dementia Care. J Am Geriatr Soc. 2020 Jul;68:S14-S20. doi: 10.1111/jgs.16618. PMID: 32589282; PMCID: PMC7393801.
Copy Download .nbib Format: NLM
The importance of decision intent within descriptions of pragmatic trials.

Journal of clinical epidemiology

Nicholls SG, Zwarenstein M, Hey SP, Giraudeau B, Campbell MK, Taljaard M.
PMID: 32422248
J Clin Epidemiol. 2020 Sep;125:30-37. doi: 10.1016/j.jclinepi.2020.04.030. Epub 2020 May 15.

OBJECTIVE: It is now more than 50 years since the concepts of explanatory and pragmatic attitudes toward trials were first discussed by Schwartz and Lellouch in their influential 1967 paper. Since then, there has been increasing focus on design...

Cite
Nicholls SG, Zwarenstein M, Hey SP, et al. The importance of decision intent within descriptions of pragmatic trials. J Clin Epidemiol. 2020;125:30-37doi: 10.1016/j.jclinepi.2020.04.030.
Nicholls, S. G., Zwarenstein, M., Hey, S. P., Giraudeau, B., Campbell, M. K., & Taljaard, M. (2020). The importance of decision intent within descriptions of pragmatic trials. Journal of clinical epidemiology, 12530-37. https://doi.org/10.1016/j.jclinepi.2020.04.030
Nicholls, Stuart G, et al. "The importance of decision intent within descriptions of pragmatic trials." Journal of clinical epidemiology vol. 125 (2020): 30-37. doi: https://doi.org/10.1016/j.jclinepi.2020.04.030
Nicholls SG, Zwarenstein M, Hey SP, Giraudeau B, Campbell MK, Taljaard M. The importance of decision intent within descriptions of pragmatic trials. J Clin Epidemiol. 2020 Sep;125:30-37. doi: 10.1016/j.jclinepi.2020.04.030. Epub 2020 May 15. PMID: 32422248.
Copy Download .nbib Format: NLM
Evidence from Pragmatic Trials during Routine Care - Slouching toward a Learning Health System.

The New England journal of medicine

Simon GE, Platt R, Hernandez AF.
PMID: 32294344
N Engl J Med. 2020 Apr 16;382(16):1488-1491. doi: 10.1056/NEJMp1915448.

No abstract available.

Cite
Simon GE, Platt R, Hernandez AF. Evidence from Pragmatic Trials during Routine Care - Slouching toward a Learning Health System. N Engl J Med. 2020;382(16):1488-1491doi: 10.1056/NEJMp1915448.
Simon, G. E., Platt, R., & Hernandez, A. F. (2020). Evidence from Pragmatic Trials during Routine Care - Slouching toward a Learning Health System. The New England journal of medicine, 382(16), 1488-1491. https://doi.org/10.1056/NEJMp1915448
Simon, Gregory E, et al. "Evidence from Pragmatic Trials during Routine Care - Slouching toward a Learning Health System." The New England journal of medicine vol. 382,16 (2020): 1488-1491. doi: https://doi.org/10.1056/NEJMp1915448
Simon GE, Platt R, Hernandez AF. Evidence from Pragmatic Trials during Routine Care - Slouching toward a Learning Health System. N Engl J Med. 2020 Apr 16;382(16):1488-1491. doi: 10.1056/NEJMp1915448. PMID: 32294344.
Copy Download .nbib Format: NLM
Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute.

Trials

Norton WE, Zwarenstein M, Czajkowski S, Kato E, O'Mara A, Shelburne N, Chambers DA, Loudon K.
PMID: 31881919
Trials. 2019 Dec 27;20(1):779. doi: 10.1186/s13063-019-3934-y.

BACKGROUND: Building capacity in research funding organizations to support the conduct of pragmatic clinical trials is an essential component of advancing biomedical and public health research. To date, efforts to increase the ability to design and carry out pragmatic...

Cite
Norton WE, Zwarenstein M, Czajkowski S, et al. Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute. Trials. 2019;20(1):779doi: 10.1186/s13063-019-3934-y.
Norton, W. E., Zwarenstein, M., Czajkowski, S., Kato, E., O'Mara, A., Shelburne, N., Chambers, D. A., & Loudon, K. (2019). Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute. Trials, 20(1), 779. https://doi.org/10.1186/s13063-019-3934-y
Norton, Wynne E, et al. "Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute." Trials vol. 20,1 (2019): 779. doi: https://doi.org/10.1186/s13063-019-3934-y
Norton WE, Zwarenstein M, Czajkowski S, Kato E, O'Mara A, Shelburne N, Chambers DA, Loudon K. Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute. Trials. 2019 Dec 27;20(1):779. doi: 10.1186/s13063-019-3934-y. PMID: 31881919; PMCID: PMC6935210.
Copy Download .nbib Format: NLM
Real-World Evidence: A Primer.

Journal of orthopaedic trauma

Zura R, Irwin DE, Mack CD, Aldridge ML, Mackowiak JI.
PMID: 33587539
J Orthop Trauma. 2021 Mar 01;35:S1-S5. doi: 10.1097/BOT.0000000000002037.

SUMMARY: The insights that real-world data (RWD) can provide, beyond what can be learned within the traditional clinical trial setting, have gained enormous traction in recent years. RWD, which are increasingly available and accessible, can further our understanding of...

Cite
Zura R, Irwin DE, Mack CD, et al. Real-World Evidence: A Primer. J Orthop Trauma. 2021;35:S1-S5doi: 10.1097/BOT.0000000000002037.
Zura, R., Irwin, D. E., Mack, C. D., Aldridge, M. L., & Mackowiak, J. I. (2021). Real-World Evidence: A Primer. Journal of orthopaedic trauma, 35S1-S5. https://doi.org/10.1097/BOT.0000000000002037
Zura, Robert, et al. "Real-World Evidence: A Primer." Journal of orthopaedic trauma vol. 35 (2021): S1-S5. doi: https://doi.org/10.1097/BOT.0000000000002037
Zura R, Irwin DE, Mack CD, Aldridge ML, Mackowiak JI. Real-World Evidence: A Primer. J Orthop Trauma. 2021 Mar 01;35:S1-S5. doi: 10.1097/BOT.0000000000002037. PMID: 33587539.
Copy Download .nbib Format: NLM
Commentary: View from the frontline of pragmatic trials.

BMJ (Clinical research ed.)

Woodcock A.
PMID: 28615287
BMJ. 2017 Jun 14;357:j2837. doi: 10.1136/bmj.j2837.

No abstract available.

Cite
Woodcock A. Commentary: View from the frontline of pragmatic trials. BMJ. 2017;357:j2837doi: 10.1136/bmj.j2837.
Woodcock, A. (2017). Commentary: View from the frontline of pragmatic trials. BMJ (Clinical research ed.), 357j2837. https://doi.org/10.1136/bmj.j2837
Woodcock, Ashley. "Commentary: View from the frontline of pragmatic trials." BMJ (Clinical research ed.) vol. 357 (2017): j2837. doi: https://doi.org/10.1136/bmj.j2837
Woodcock A. Commentary: View from the frontline of pragmatic trials. BMJ. 2017 Jun 14;357:j2837. doi: 10.1136/bmj.j2837. PMID: 28615287.
Copy Download .nbib Format: NLM
Informed consent for comparative effectiveness trials.

The New England journal of medicine

Williams RT.
PMID: 24827056
N Engl J Med. 2014 May 15;370(20):1959. doi: 10.1056/NEJMc1403310.

No abstract available.

Cite
Williams RT. Informed consent for comparative effectiveness trials. N Engl J Med. 2014;370(20):1959doi: 10.1056/NEJMc1403310.
Williams, R. T. (2014). Informed consent for comparative effectiveness trials. The New England journal of medicine, 370(20), 1959. https://doi.org/10.1056/NEJMc1403310
Williams, Robin T W. "Informed consent for comparative effectiveness trials." The New England journal of medicine vol. 370,20 (2014): 1959. doi: https://doi.org/10.1056/NEJMc1403310
Williams RT. Informed consent for comparative effectiveness trials. N Engl J Med. 2014 May 15;370(20):1959. doi: 10.1056/NEJMc1403310. PMID: 24827056.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries